From Zero to $40 Billion Vaccine Marker Overnight: Welcome to the COVID-19 Vaccine Market
COVID-19 has become a big business, a really big business. Going from nothing to a $40 billion dollar market, at least […]
COVID-19 has become a big business, a really big business. Going from nothing to a $40 billion dollar market, at least […]
A prominent U.S. military commander, Admiral Craig Fuller recently suggested in a video conference involving members of the Defense Writers […]
Bamlanivimab: Monoclonal Antibody Treatment Presents Special Difficulties in Administration:The medical and research establishments certainly have given their best during this […]
In early September, the AstraZeneca/Oxford vaccine trials were put on temporary hold across all international testing sites due to a […]
The Russian vaccine known as “Sputnik V,” developed by the Gamaleya National Research Institute of Epidemiology and Microbiology, was registered […]
Moderna just today gave its Third Quarter 2020 Conference Call based on its earnings report, while disclosing its preparation for […]
Pfizer’s BNT162b2 appears to be in the lead of all “Western” vaccines that have any chance for emergency use authorization […]
The nation of Indonesia, the fourth most populous worldwide, has inked a deal with AstraZeneca to buy 100 million COVID-19 […]
Bangladesh’s health ministry has rejected calls by China’s Sinovac Biotech to co-finance a Phase 3 COVID-19 vaccine-focused clinical trial in […]
Egypt reports via its Minister of Higher Education and Scientific Research that that influential Arabic nation will conduct two Phase […]